Global Technology Briefing


A team of researchers from Tel Aviv University has demonstrated that two antibodies isolated from the immune system of recovered COVID-19 patients are effective in neutralizing all known strains of the virus, including the Delta and the Omicron variants. As explained in the journal Nature Communications Biology , this discovery may eliminate the need for repeated booster vaccinations and strengthen the immune .....
This content is for BUSINESS BRIEFINGS members only.

Website and apps by ePublisher